Chemotherapy for advanced bladder carcinoma: new molecules and regimens
Abi-Aad, A.S.
Acta Urologica Belgica 64(2): 43-45
1996
ISSN/ISBN: 0001-7183 PMID: 8701810 Document Number: 462599
Document emailed within 1 workday
Related Documents
Raghavan, D.; Pearson, B.; Watt, W.H.; Mameghan, H.; Langdon, P.; Eisinger, D.; Wines, R. 1991: Cytotoxic chemotherapy for advanced bladder cancer: cisplatin-containing regimens Seminars in Oncology 18(1 Suppl 3): 56-63Yang, H.; Yao, J.; Wen, H.; Yu, L.; Liu, W.; Liang, H.; Han, S. 2015: Clinical evaluations of neoadjuvant chemotherapy with DN and FP regimens for patients with middle or lower thoracic locally advanced esophageal squamous cell carcinoma Zhonghua Yi Xue Za Zhi 95(19): 1530-1533
Serretta, V.; Vasile, P.; Falletta, V.; Piazza, F.; Pavone, C.; Pavone-Macaluso, M. 1998: Conservative treatment of locally advanced bladder carcinoma: neoadjuvant chemotherapy, TUR and radiotherapy. Results in 40 patients Archivio Italiano di Urologia Andrologia: Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 70(3 Suppl): 37-40
Monica, B.; Larosa, M.; Frattini, A.; Macaluso, G.; Cocconi, G.; Passalacqua, R.; Leonardi, F. 1994: Neoadjuvant chemotherapy in advanced-stage bladder carcinoma. a randomized prospective study comparing MVAC and MVEEC Archivio Italiano di Urologia Andrologia: Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 66(5): 235-243
Dubey, S.; Brown, R.L.; Esmond, S.L.; Bowers, B.J.; Healy, J.M.; Schiller, J.H. 2005: Patient preferences in choosing chemotherapy regimens for advanced non-small cell lung cancer Journal of Supportive Oncology 3(2): 149-154
Vogl, S.E.; Berenzweig, M.; Kaplan, B.H.; Moukhtar, M.; Bulkin, W. 1979: The CHAD and HAD regimens in advanced ovarian cancer: combination chemotherapy including cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II) Cancer Treatment Reports 63(2): 311-317
Yoshida, K.; Takahashi, T.; Nakame, Y.; Saitoh, H.; Horiuchi, S.; Kaneoya, F.; Negishi, T. 1987: Bladder instillation of verapamil as a means of enhancing the efficacy of chemotherapy in superficial bladder carcinoma: influence of bladder instillation of verapamil on the cardiovascular system Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(2): 506-510
Jakse, G.; Frommhold, H. 1984: Combined radiation and chemotherapy for locally advanced bladder cancer Progress in Clinical and Biological Research 153: 365-372
Nishikawa, A.; Hashimoto, H.; Takeda, M.; Kontani, K.; Miyatake, T.; Mimura, M.; Nagamatsu, M.; Yokoi, T. 2016: Retrospective analysis of the survival benefit of chemotherapy for recurrent or advanced epithelial ovarian carcinoma in patients previously treated with paclitaxel plus platinum-based chemotherapy European Journal of Gynaecological Oncology 37(4): 451-454
Li, X.-f.; Li, Y.-h.; Gao, Y.-n.; Li, C.-l.; Yue, H.-z.; Xu, G.; Li, D.-m.; Su, X. 2013: Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix Zhonghua Fu Chan Ke Za Zhi 48(10): 763-767
Scher, H.I. 1992: Systemic chemotherapy in regionally advanced bladder cancer. Theoretical considerations and results Urologic Clinics of North America 19(4): 747-759
Sengeløv, L.; von der Maase, H. 2005: Chemotherapy as a supplement to radical treatment of patients with locally advanced bladder cancer Ugeskrift for Laeger 167(7): 749-751
Yagoda, A. 1977: Future implications of phase 2 chemotherapy trials in ninety-five patients with measurable advanced bladder cancer Cancer Research 37(8 Part 2): 2775-2780
Pasmantier, M.W.; Coleman, M.; Silver, R.T.; Ballard, W.P. 1985: Six-drug chemotherapy (hexamethylmelamine, doxorubicin, cisplatin, cyclophosphamide, methotrexate, and 5-FU; CHAMP-5) for ovarian carcinoma: alternating sequences of combination regimens Cancer Treatment Reports 69(6): 689-693
Schmiedt, E. 1973: Advanced bladder carcinoma, 1970 until June 1972 Helvetica Chirurgica Acta 40(4): 443-447
Tajiri, H.; Yoshimori, M.; Hijikata, A.; Nakamura, K.; Ohkura, H.; Okazaki, N. 1987: Cis-diamminedichloroplatinum(II) chemotherapy in advanced pancreatic carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(11): 3101-3104
Uchida, T.; Kobayashi, K.; Arakawa, T.; Omata, T.; Li, K.; Ikeda, S.; Endo, T.; Ishibashi, A.; Koshiba, K. 1984: Chemotherapy of advanced genitourinary carcinoma with cis-diamminedichloroplatinum Hinyokika Kiyo. Acta Urologica Japonica 30(9): 1173-1183
Lorvidhaya, V.; Tonusin, A.; Sukthomya, W.; Changwiwit, W.; Nimmolrat, A. 1995: Induction chemotherapy and irradiation in advanced carcinoma of the cervix Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(Suppl 3): 244-251
Mottet, N.; Di Palma, M.; Costa, P. 2000: Simultaneous radio-chemotherapy for infiltrating bladder carcinoma. what is new since 1997? Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 10(4): 513-519
Persiani, R.; D'Ugo, D.; Biondi, A.; Rausei, S.; Vigorita, V.; Zoccali, M.; Picciocchi, A. 2005: T-downstaging after neoadjuvant chemotherapy in locally advanced gastric carcinoma I Suppli di Tumori: Official Journal of Societa Italiana di Cancerologia . 4(3): S88